Having this goal in mind, one of the most explored options over the last years has been immunization using HSP60 peptides, seeking after the ideal candidates for the development of vaccines to provide novel therapies for the treatment of cardiovascular disease as a result of peripheral tolerance induction to the HSPs and its peptides (75). Here, HSPD1 is linked to cardiovascular disorder.